Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Prediction of Antihypertensive Effect: Olmesartan vs Chlorthalidone
NCT03560804Completed
- Sponsor
- AHEPA University Hospital
- Start
- Nov 2014
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in hypertension (HTN) comparing Olmesartan with Chlorthalidone (2 arms). Primary endpoint: Pulse Wave Velocity at 12 weeks. Started Nov 2014; status: completed.
02
Drugs
olmesartanchlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03560804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03560804.